nuvox_logo 1000 - svg.jpg
  • Pipeline

  • Leadership

  • News

    • Events
  • Publications

    • Acute Hypoxemic Respiratory Failure
    • Hemorrhagic Shock
    • Mechanism Of Action
    • Myocardial Infarction
    • Oncology
    • Pharmacokinetics
    • Stroke
    • Traumatic Brain Injury
  • Careers

  • Contact

  • More

    Use tab to navigate through the menu items.

    Myocardial Infarction

    Imaging assessment of cardioprotection mediated by DDFPe administered during myocardial infarction

    Imaging assessment of cardioprotection mediated by DDFPe administered during myocardial infarction

    DDFPe treatment in rats with myocardial infarction was associated by significantly reduced ischemia-reperfusion injury.
    DDFPe Elicits Cardiac Protection Against Myocardial Infarction

    DDFPe Elicits Cardiac Protection Against Myocardial Infarction

    Rats given DDFPe see a 72% reduction in myocardial infarct volume at 24 hours.
    • Pipeline
    • Leadership
    • News
      • Events
    • Publications
      • Acute Hypoxemic Respiratory Failure
      • Hemorrhagic Shock
      • Mechanism Of Action
      • Myocardial Infarction
      • Oncology
      • Pharmacokinetics
      • Stroke
      • Traumatic Brain Injury
    • Careers
    • Contact

    NuvOx Pharma

    1635 E 18th Street

    Tucson, Arizona 85719

    ​

    Privacy Policy

    Terms & Conditions

    Company FCOI

    ​

    © 2020 NuvOx Pharma